[HTML][HTML] Primary stroke prevention worldwide: translating evidence into action

MO Owolabi, AG Thrift, A Mahal, M Ishida… - The Lancet Public …, 2022 - thelancet.com
Stroke is the second leading cause of death and the third leading cause of disability
worldwide and its burden is increasing rapidly in low-income and middle-income countries …

Reactive oxygen species scavenging nanomedicine for the treatment of ischemic heart disease

Z Zhang, R Dalan, Z Hu, JW Wang… - Advanced …, 2022 - Wiley Online Library
Ischemic heart disease (IHD) is the leading cause of disability and mortality worldwide.
Reactive oxygen species (ROS) have been shown to play key roles in the progression of …

[HTML][HTML] Chlorthalidone vs. hydrochlorothiazide for hypertension–cardiovascular events

A Ishani, WC Cushman, SM Leatherman… - … England Journal of …, 2022 - Mass Medical Soc
Background Whether chlorthalidone is superior to hydrochlorothiazide for preventing major
adverse cardiovascular events in patients with hypertension is unclear. Methods In a …

2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of …

G Mancia, R Kreutz, M Brunström, M Burnier… - Journal of …, 2023 - journals.lww.com
Document Reviewers: Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …

Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial

MP Schlaich, M Bellet, MA Weber, P Danaietash… - The Lancet, 2022 - thelancet.com
Background Resistant hypertension is associated with increased cardiovascular risk. The
endothelin pathway has been implicated in the pathogenesis of hypertension, but it is …

[HTML][HTML] Modeling global 80-80-80 blood pressure targets and cardiovascular outcomes

SJ Pickersgill, WT Msemburi, L Cobb, N Ide… - Nature medicine, 2022 - nature.com
As the leading cause of death worldwide, cardiovascular diseases (CVDs) present major
challenges for health systems. In this study, we analyzed the effects of better population …

Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease

K Matsushita, SH Ballew, AYM Wang… - Nature Reviews …, 2022 - nature.com
Chronic kidney disease (CKD) is defined by a low glomerular filtration rate or high
albuminuria, and affects 15–20% of adults globally. CKD increases the risk of various …

[HTML][HTML] Effects of elevated systolic blood pressure on ischemic heart disease: a Burden of Proof study

C Razo, CA Welgan, CO Johnson, SA McLaughlin… - Nature Medicine, 2022 - nature.com
High systolic blood pressure (SBP) is a major risk factor for ischemic heart disease (IHD), the
leading cause of death worldwide. Using data from published observational studies and …

[HTML][HTML] Exercise training and resting blood pressure: a large-scale pairwise and network meta-analysis of randomised controlled trials

JJ Edwards, AHP Deenmamode, M Griffiths… - British Journal of …, 2023 - bjsm.bmj.com
Objective To perform a large-scale pairwise and network meta-analysis on the effects of all
relevant exercise training modes on resting blood pressure to establish optimal …

Gut microbiome and neuroinflammation in hypertension

EM Richards, J Li, BR Stevens, CJ Pepine… - Circulation …, 2022 - Am Heart Assoc
Hypertension is a worldwide problem with major impacts on health including morbidity and
mortality, as well as consumption of health care resources. Nearly 50% of American adults …